Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0RSYON
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
ITC-6102RO
|
|||||
| Synonyms |
ITC-6102RO
Click to Show/Hide
|
|||||
| Organization |
Asan Medical Center; University of Ulsan College of Medicine; Asan Institute for Life Sciences; Asan Medical Institute of Convergence Science and Technology; Asan Preclinical Evaluation Center for Cancer Therapeutics; Chung-Ang University; IntoCell Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Structure |
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
CD276 antigen (CD276)
|
Antigen Info | ||||
| Payload Name |
Benzodiazepine dimer derivative
|
Payload Info | ||||
| Therapeutic Target |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
|
Target Info | ||||
| Linker Name |
Maleimide-containing OHPAS linker
|
Linker Info | ||||